about
Clinical and therapeutic aspects of Klinefelter's syndrome: sexual function.Testosterone therapy in men with Crohn's disease improves the clinical course of the disease: data from long-term observational registry study.A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia.Clinical correlates of enlarged prostate size in subjects with sexual dysfunctionRegulation of epididymal contractility during semen emission, the first part of the ejaculatory process: a role for estrogen.Testosterone and sexual activity.Peripheral regulatory mechanisms in erection.PDE5-Is for the Treatment of Concomitant ED and LUTS/BPH.Negative effects of high glucose exposure in human gonadotropin-releasing hormone neurons.Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions.Metabolic syndrome and prostate abnormalities in male subjects of infertile couples.Klinefelter's syndrome: a clinical and therapeutical update.Male pubertal development: role of androgen therapy on bone mass and body composition.Consensus statement on diagnosis and clinical management of Klinefelter syndrome.Benign prostatic hyperplasia: a new metabolic disease?Management of benign prostatic hyperplasia: role of phosphodiesterase-5 inhibitors.Obesity and late-onset hypogonadism.Testosterone supplementation and body composition: results from a meta-analysis of observational studies.The Impact of Central Obesity on Storage Luts and Urinary Incontinence After Prostatic Surgery.Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: a role for GPR30/GPER?Meta-analysis of metabolic syndrome and prostate cancer.Bringing the body of the iceberg to the surface: the Female Sexual Dysfunction Index-6 (FSDI-6) in the screening of female sexual dysfunction.Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum.Identification, localization and functional in vitro and in vivo activity of oxytocin receptor in the rat penis.Metabolic syndrome and lower urinary tract symptoms: the role of inflammation.Cardiovascular risk engines can help in selecting patients to be evaluated by dynamic penile color doppler ultrasound.Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA/Rho-kinase signaling hyperactivation.Oxytocin mediates the estrogen-dependent contractile activity of endothelin-1 in human and rabbit epididymis.Effect of sildenafil administration on penile hypoxia induced by cavernous neurotomy in the rat.Tumor Necrosis Factor-α Impairs Kisspeptin Signaling in Human Gonadotropin-Releasing Hormone Primary Neurons.Role of Sexuality in the Outcome of Anorexia Nervosa and Bulimia Nervosa: A 3-Year Follow-Up Study.Which are the male factors associated with female sexual dysfunction (FSD)?The International Society for the Study of Women's Sexual Health Process of Care for Management of Hypoactive Sexual Desire Disorder in Women.Identification, characterization and biological activity of oxytocin receptor in the developing human penis.Reply to Jae Heon Kim's Letter to the Editor re: Mauro Gacci, Giovanni Corona, Arcangelo Sebastianelli, et al. Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis. Eur Urol 2016;70:788-96INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial functionRole of Androgens in Female Genitourinary Tissue Structure and Function: Implications in the Genitourinary Syndrome of MenopauseThe role of androgens in the treatment of genitourinary syndrome of menopause (GSM)Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndromeValidation of a Visual Analogue Scale to measure the subjective perception of orgasmic intensity in females: The Orgasmometer-F
P50
Q27687554-99422226-DC20-4E8F-95A2-C87F87219EECQ30960535-1A1978CF-9CA1-4AF4-9576-B66E984C08CAQ34190455-348A79CA-3F02-4670-BD8B-ACC6BDB00D6AQ34433316-D51BE1A1-A283-4539-A10B-397D5FF30CA3Q34824892-8328CE4F-6992-4A40-9BAF-DF7F222333E9Q36206217-0369A7F9-499C-4293-893E-696B9DBB5CCFQ36290972-CDBA0173-CE73-4CDF-BACB-02960F270576Q37025381-6BDB632E-EAC0-46A1-A34D-3122309C8F5FQ37486480-F5FDA1D3-0782-434C-A58C-8496811A6DC6Q37618958-4E4BE088-59CE-4345-9019-0CA2BA1C9E19Q37639222-23B5EAB3-13A1-455C-AA63-9AE85897E9FDQ37776099-AB7226BA-F597-44EE-A5C5-6AE3741489C3Q37799490-C44C1422-41C8-4E86-B668-BDD4DF4E22A4Q37835641-DD32433A-12B9-4179-8E73-7FD99AF46A8DQ38181426-F83FA9BE-7AFC-4AA7-A778-06E177B0AC61Q38210468-DD50766D-6414-42C1-85C2-18A761D95C02Q38542906-F4703183-1478-499C-B781-8E7D41F07D91Q38848541-301B1652-F68D-43CA-A283-F42321730E47Q38901781-BAF3C60E-6280-4438-99A8-46C8AA3A4AD2Q39095837-49987E21-19EB-4B83-85B7-3727D9C3B152Q39145052-85280C6B-223D-4E48-A9CB-E6FFE6179A40Q41427463-93539D95-1A15-473B-9977-084A48FF7237Q45269760-EA0CD5F7-DCA5-4E4E-B9FB-3D1E09957BAEQ45304745-2BCF4CC1-AF61-45F9-AE7D-9D7559FF385DQ45784694-A39C8679-B11A-427E-B7DD-890315697DCBQ46107133-D616006D-E95A-4379-8A8E-56E6029904A7Q46146298-976766FA-2BC4-42C9-BB81-F083E561C876Q46462997-97157264-8A42-46F7-9F88-95614489BE9BQ48459547-201BC432-1578-4FC0-AAF3-3C4662FB99CEQ49233130-67CED4DC-B3AA-4964-B6CB-66530320CD92Q50050557-46E1F219-D8DA-4DE8-B763-CB883A68A5A9Q50876770-94E27930-F1D4-44B0-98FB-09BCE7C7BB01Q51762746-FCB62FD2-D22A-42DC-B102-13A87F8EFEB0Q52062781-3B2C3253-4F23-4830-8007-EF740207046AQ56960565-D4017443-3B59-45A1-97D4-A74265737C80Q57113213-4BC7CC57-70DB-45DD-B04D-7D08404FCCD3Q57373605-C1DD1DFA-703B-4078-A96F-45E7ABE80B82Q57378871-BA4991E8-0A05-4C42-82BC-743B4A9D490DQ57582289-CC68840E-FA7D-425B-B0D4-C2758D50B48DQ58696604-7142073E-78A9-4765-9FA3-CB275A538300
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Linda Vignozzi
@en
Linda Vignozzi
@nl
type
label
Linda Vignozzi
@en
Linda Vignozzi
@nl
prefLabel
Linda Vignozzi
@en
Linda Vignozzi
@nl
P31
P496
0000-0003-0907-0630